The additional value of ultrasound markers in the diagnosis of polycystic ovary syndrome

被引：2
作者：
van der Ham, Kim [1 ]
Barbagallo, Federica [2 ]
van Schilfgaarde, Emiliya [1 ]
Lujan, Marla E. [3 ]
Laven, Joop S. E. [1 ]
Louwers, Yvonne V.
机构：
[1] Erasmus MC, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Rotterdam, Netherlands
[2] Univ Catania, Dept Clin & Expt Med, Catania, Italy
[3] Cornell Univ, Coll Human Ecol & Agr & Life Sci, Human Metab Res Unit, Div Nutr Sci, Ithaca, NY USA
来源：
FERTILITY AND STERILITY | 2025年 / 123卷 / 02期
关键词：
PCOS; ultrasonography; follicle count; ovarian volume; WOMEN; VOLUME;
D O I：
10.1016/j.fertnstert.2024.08.342
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Objective: To study the value of current definitions for follicle number per ovary and ovarian volume in the diagnosis of polycystic ovary syndrome (PCOS). Design: Cross-sectional study. Subjects: Women diagnosed with PCOS after standardized screening were eligible for inclusion in the PCOS group. Women without PCOS who underwent the same screening, had regular menstrual cycles, normal hormonal values, and no other endocrine pathology were eligible for inclusion. Exposure: Not applicable. Main Outcome Measure(s): Follicle number per ovary and ovarian volume in women with PCOS, stratified by age. Linear regression models to investigate the influence of body mass index (BMI) on follicle number per ovary and ovarian volume. Differences in follicle number per ovary and ovarian volume between the PCOS phenotypes and the additional value of ovarian volume compared with follicle number per ovary. Result(s): A total of 2,492 women (16-50 years) with PCOS and 152 women without PCOS were included. Most women with PCOS up to age of 35 exhibit a follicle number per ovary >= 20 (87.8%-100%) (using an ultrasound transducer >= 8 MHz) or >= 12 (95.1%-98.6%) (using a transducer <8 MHz), followed by a decline in follicle number per ovary >35 years. Median ovarian volume was below the 10 mL cutoff in every age group, for both ultrasound transducers. Follicle number per ovary and ovarian volume were higher in women with PCOS compared with women without PCOS in every age category. In our cohort, 13/2,297 women with PCOS (0.6%) would not have received the diagnosis if ovarian volume was not considered a marker for polycystic ovarian morphology. For both ultrasound transducers, women with phenotype A (ovulatory dysfunction + hyperandrogenism + polycystic ovarian morphology) exhibited the highest follicle number per ovary and ovarian volume, followed by phenotype D (ovulatory dysfunction + polycystic ovarian morphology), then phenotype C (hyperandrogenism + polycystic ovarian morphology), and then phenotype B (ovulatory dysfunction + hyperandrogenism). No clinically significant correlation between BMI and follicle number per ovary or ovarian volume was observed. Conclusion(s): Criteria to define follicle number per ovary should be established per age category, as follicle number per ovary decreases with age. Ovarian volume shows a less clear decline with age and has a lower discriminative power, and therefore could be excluded from the diagnostic criteria. Follicle number per ovary does not need to be stratified by BMI. (Fertil Steril (R) 2025;123: 342-9. (c) 2024 by American Society for Reproductive Medicine.)
引用
收藏
页码：342 / 349
页数：8
相关论文
共 22 条
  • [1] Teede H.J., Tay C.T., Laven J.J.E., Dokras A., Moran L.J., Piltonen T.T., Et al., Recommendations from the 2023 International Evidence-Based Guideline for the assessment and management of polycystic ovary syndrome, J Clin Endocrinol Metab, 108, pp. 2447-2469, (2023)
  • [2] Bozdag G., Mumusoglu S., Zengin D., Karabulut E., Yildiz B.O., The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis, Hum Reprod, 31, pp. 2841-2855, (2016)
  • [3] Teede H.J., Misso M.L., Costello M.F., Dokras A., Laven J., Moran L., Et al., Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Fertil Steril, 110, pp. 364-379, (2018)
  • [4] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum Reprod, 19, pp. 41-47, (2004)
  • [5] Teede H.J., Tay C.T., Laven J.J.E., Dokras A., Moran L.J., Piltonen T.T., Et al., Technical report for: International Evidence-Based Guideline for the assessment and management of polycystic ovary syndrome, (2023)
  • [6] Pea J., Bryan J., Wan C., Oldfield A.L., Ganga K., Carter F.E., Et al., Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis, Hum Reprod Update, 30, pp. 109-130, (2024)
  • [7] Moslehi N., Shab-Bidar S., Ramezani Tehrani F., Mirmiran P., Azizi F., Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis, Menopause, 25, pp. 1046-1055, (2018)
  • [8] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril, 81, pp. 19-25, (2004)
  • [9] Zhao X., Ni R., Li L., Mo Y., Huang J., Huang M., Et al., Defining hirsutism in Chinese women: a cross-sectional study, Fertil Steril, 96, pp. 792-796, (2011)
  • [10] Bui H.N., Sluss P.M., Hayes F.J., Blincko S., Knol D.L., Blankenstein M.A., Et al., Testosterone, free testosterone, and free androgen index in women: reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome, Clin Chim Acta, 450, pp. 227-232, (2015)
123